In addition BMSN can commence the human clinical trial after 30 days if they haven't been contact by the FDA that there are some concern that need to be addressed or they can commence it immediately within the 30 days if the FDA indicates that they are able to. They can also contact BMSN any time immediately and say they need more details/research regarding their IND. So technically, they don't approve or deny IND.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.